Singapore markets closed
Straits Times Index
3,280.10 -7.65 (-0.23%) Nikkei
37,934.76 +306.28 (+0.81%) Hang Seng
17,651.15 +366.61 (+2.12%) FTSE 100
8,139.83 +60.97 (+0.75%) Bitcoin USD
63,028.12 -1,391.25 (-2.16%) CMC Crypto 200
1,304.48 -92.06 (-6.59%)
ANI Pharmaceuticals, Inc. (ANIP)
NasdaqGM - NasdaqGM Real-time price. Currency in USD
Add to watchlist
At close: 04:00PM EDT
After hours:
| Previous close | 64.95 |
| Open | 64.95 |
| Bid | 65.16 x 300 |
| Ask | 65.37 x 100 |
| Day's range | 64.68 - 65.60 |
| 52-week range | 37.40 - 70.81 |
| Volume | |
| Avg. volume | 144,136 |
| Market cap | 1.371B |
| Beta (5Y monthly) | 0.80 |
| PE ratio (TTM) | 76.89 |
| EPS (TTM) | N/A |
| Earnings date | N/A |
| Forward dividend & yield | N/A (N/A) |
| Ex-dividend date | N/A |
| 1y target est | N/A |
- Zacks
Sage Therapeutics (SAGE) Q1 Earnings Miss, Sales Beat Estimates
Sage Therapeutics' (SAGE) first-quarter 2024 results are mixed as earnings miss estimates, but sales beat the mark. The newly-launched depression drug Zurzuvae drives the company's top line.
- Zacks
Sage (SAGE) Down 20% on Parkinson's Study Missing Primary Goal
Data from a mid-stage study show that Sage's (SAGE) experimental oral drug failed to show a statistically significant difference in treating patients with Parkinson's disease compared with a placebo.
- Zacks
GSK Announces FDA Acceptance of New Meningococcal Jab BLA
The approval of GSK's 5-in-1 meningococcal ABCWY vaccine candidate, MenABCWY, could provide the broadest meningococcal serogroup coverage and lead to simplified immunization.
© 2024 Yahoo. All rights reserved.